1. Effects of melatonin and metformin on the ovaries of rats with polycystic ovary syndrome.
- Author
-
Lombardi LA, Mattos LS, Espindula AP, Simões RS, Sasso GRDS, Simões MJ, Soares-Jr JM, and Florencio-Silva R
- Subjects
- Animals, Female, Rats, Apoptosis drug effects, Caspase 3 metabolism, Disease Models, Animal, Ki-67 Antigen metabolism, Ki-67 Antigen analysis, Metformin pharmacology, Metformin administration & dosage, Polycystic Ovary Syndrome drug therapy, Polycystic Ovary Syndrome pathology, Polycystic Ovary Syndrome chemically induced, Melatonin pharmacology, Melatonin administration & dosage, Ovary drug effects, Ovary pathology, Rats, Wistar
- Abstract
Objective: To study the combined and isolated effects of melatonin and metformin in the ovarian tissue of rats with PCOS., Design: Experimental study using a rat model of PCOS induced by continuous light exposure., Intervention(s): Forty adult female rats were divided into 5 groups: physiological estrus phase (Sham); permanente estrus with PCOS induced by continuous lighting exposure for 60 consecutive days (control); with PCOS treated with melatonin; with PCOS treated with metformin; with PCOS treated with melatonin + metformin. After 60 days of treatments, all rats were killed, and ovaries were collected and processed for paraffin-embedding. Formalin-fixed paraffin-embedded sections were stained with hematoxylin and eosin or subjected to immunohistochemistry for proliferation (Ki-67) and apoptosis (cleaved caspase 3) detection markers., Setting: Federal University of São Paulo, Brazil., Animals: Forty adult female Wistar rats (Rattus norvegicus albinus)., Main Outcome Measure(s): Number of corpus luteum and ovarian cysts, number of ovarian follicles (primary and antral follicles), number of interstitial cells, percentage of ovarian follicles (primary and antral follicles), and of interstitial cells immunostained to cleaved caspase-3 and Ki-67., Results: Absence of corpus luteum, a higher number of cysts, and increased nuclear volume and area of interstitial cells, along with a decrease in primary and antral follicle numbers, were noticed in the control group compared with the Sham group. Melatonin and metformin treatments attenuated these effects, although the combined treatment did not mitigate the increased number of cysts and ovaries induced by PCOS. An increase in theca interna cell apoptosis was observed in the control group, whereas melatonina and metformin treatments reduced it significantly. A higher percentage of caspase-3-immunostained granulosa cells was noted in the Sham and all treated groups compared with the control group; no aditive effects on ovarian cell apoptosis were observed in the combined treatment. The percentage of Ki-67- immunostained granulosa cells was significantly higher in the control group compared with the Sham group. However, the combined treatment, not melatonin and metformin alone, mitigated this effect. A higher percentage of Ki-67-immunostained interstitial cells was observed in all treated groups compared with the Sham and control groups, whereas no additive effects in that immunoreactivity were observed in the combined treatment., Conclusions: Melatonin and metformin may improve ovarian function in rats with PCOS. The combined melatonin and metformin treatment is more effective in attenuating excessive granulosa cell proliferation, but it is not more effective in improving ovarian function than these drugs applied alone in rats with PCOS., Competing Interests: Declaration of Interests L.A.L. has nothing to disclose. L.S.M. has nothing to disclose. A.P.E. has nothing to disclose. R.S.S. has nothing to disclose. G.R.D.S.S. has nothing to disclose. M.D.J.S. has nothing to disclose. J.M.S. has nothing to disclose. R.F.S. has nothing to disclose., (Copyright © 2024 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.) more...
- Published
- 2024
- Full Text
- View/download PDF